Why Nautilus Biotechnology (NAUT) Stock Trading Higher Thursday?

Nautilus Biotechnology Inc NAUT shares are trading higher during mid-day trading on Thursday following a CNBC report that Amazon.com Inc AMZN held around $15 million stake in the company at the end of Q2.
The $14.7 million investment was disclosed in a recent Amazon SEC Form 13F filing.
Nautilus just went public in early June after a merger with SPAC Arya Sciences Acquisition III.
Nautilus has a single-molecule protein analysis platform for quantifying the human proteome to aid biomedical research and drug discovery.
Price Action: NAUT shares are up 13.8% at $8.55 during the market session on the last check Thursday.